Cargando…
The distribution of the therapeutic monoclonal antibodies cetuximab and trastuzumab within solid tumors
BACKGROUND: Poor distribution of some anticancer drugs in solid tumors may limit their anti-tumor activity. METHODS: Here we used immunohistochemistry to quantify the distribution of the therapeutic monoclonal antibodies cetuximab and trastuzumab in relation to blood vessels and to regions of hypoxi...
Autores principales: | Lee, Carol M, Tannock, Ian F |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2889896/ https://www.ncbi.nlm.nih.gov/pubmed/20525277 http://dx.doi.org/10.1186/1471-2407-10-255 |
Ejemplares similares
-
Influence of the proton pump inhibitor lansoprazole on distribution and activity of doxorubicin in solid tumors
por: Yu, Man, et al.
Publicado: (2015) -
Strategies to enhance monoclonal antibody uptake and distribution in solid tumors
por: Bordeau, Brandon M., et al.
Publicado: (2021) -
A case of Ménétriere´s disease treated with the monoclonal antibody cetuximab
por: Carlsen, Arne, et al.
Publicado: (2019) -
Therapeutic Monoclonal Antibodies Targeting Immune Checkpoints for the Treatment of Solid Tumors
por: Gravbrot, Nicholas, et al.
Publicado: (2019) -
Expression Enhancement in Trastuzumab Therapeutic Monoclonal Antibody Production using Genomic Amplification with Methotrexate
por: Akbarzadeh-Sharbaf, Soudabeh, et al.
Publicado: (2013)